已收盘 02-06 16:00:00 美东时间
+0.820
+1.66%
BRIEF-Relay Therapeutics Announces Zovegalisib Granted Therapy Designation By FDA For Pik3ca-Mutant Feb 3 (Reuters) - Relay Therapeutics Inc RLAY.O : RELAY THERAPEUTICS ANNOUNCES ZOVEGALISIB GRANTED BREAKTHROUGH THERAPY DESIGNATION BY U.S. FDA FOR PIK3CA-MUTANT, HR+/HER2- ADVANCED BREAST CANCER Sour
02-03 21:11
Study met its primary and key secondary endpoints, demonstrating rapid and sustained improvement in near visual acuitySafety profile consistent with previous clinical trials and no treatment-related serious adverse
2025-06-26 19:02
MR-141 Met Primary And All Secondary Endpoints, Demonstrating Rapid And Sustained Improvement In Near Visual Acuity Without Compromising Distance VisionSafety Profile Consistent With Previous Clinical Trials And No
2025-06-26 19:00
First publicly traded miner to reach this scale with fully self-operated infrastructure LAS VEGAS, June 24, 2025 /PRNewswire/ -- CleanSpark, Inc. (Nasdaq: CLSK), America's Bitcoin Miner®, t...
2025-06-24 19:00
Epicurean Celebration of Food, Drink, and Culinary Icons Returns for a Second Year in September Hi-res images HERE Video sizzle reel HERE LAS VEGAS, June 18, 2025 /PRNewswire/ -- The highly...
2025-06-19 02:00
New Pure Storage FlashArray and FlashBlade offerings support the most massive demands for increasingly intensive workloads LAS VEGAS, June 18, 2025 /PRNewswire/ -- Pure//Accelerate -- Pure S...
2025-06-18 21:00
New law promotes bill predictability, customer savings, and continued regulator...
2025-06-13 02:46
First-of-its-kind integration gives hotels the ability to offer in-house guests priority access to OpenTable reservations and experiences via UrVenue's Itinerary Builder; Visit UrVenue at HITEC Indianapolis June 17 to 19
2025-06-09 22:45